Osteogenic Growth Peptide, OGP

Basic Information

View in Editor

CAS Number

132996-61-3

Molecular Formula

C68H111N23O17

Molecular Weight

1522.75 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Amines

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

SMILES

View in Editor

CC(C[C@H](NC([C@@H](N)C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(NCC(O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)CC2=CC=C(O)C=C2)=O)CC(C)C)=O)[C@H](O)C)=O)CCCNC(N)=N)=O)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCCCN)=O)C

InChI

InChI=1S/C68H110N22O18/c1-36(2)28-47(87-57(99)38(5)70)64(106)85-44(16-10-11-25-69)61(103)84-45(18-13-27-77-68(74)75)62(104)86-46(23-24-51(71)93)58(100)80-33-53(95)82-43(17-12-26-76-67(72)73)63(105)90-56(39(6)91)66(108)89-48(29-37(3)4)65(107)88-50(31-41-19-21-42(92)22-20-41)60(102)81-34-54(96)83-49(30-40-14-8-7-9-15-40)59(101)79-32-52(94)78-35-55(97)98/h7-9,14-15,19-22,36-39,43-50,56,91-92H,10-13,16-18,23-35,69-70H2,1-6H3,(H2,71,93)(H,78,94)(H,79,101)(H,80,100)(H,81,102)(H,82,95)(H,83,96)(H,84,103)(H,85,106)(H,86,104)(H,87,99)(H,88,107)(H,89,108)(H,90,105)(H,97,98)(H4,72,73,76)(H4,74,75,77)/t38-,39+,43-,44-,45-,46-,47-,48-,49-,50-,56-/m0/s1

InChIKey

VNTJGCYVIRTGMZ-PXGLAOGESA-N

LogP

-7.1687599999999385

Topological Polar Surface Area

674.9900000000001 Å²

Hydrogen Bond Donor/Acceptor

30 / 40

Synonyms & References

English

OSTEOGENIC GROWTH PEPTIDE
Osteogenic Growth Peptide OGP
H-ALA-LEU-LYS-ARG-GLN-GLY-ARG-THR-LEU-TYR-GLY-PHE-GLY-GLY-OH
Osteogenic Growth Peptide OGP
Osteogenic Growth Peptide, OGP

MDL Number

MFCD00214641

FAQ

What regulatory guidelines apply to Osteogenic Growth Peptide (CAS: 132996-61-3)?

Osteogenic Growth Peptide (OGP) must comply with regulatory guidelines such as GHS for classification and labeling, REACH for registration, evaluation, and authorization in the European Union, and FDA/EPA requirements for the United States. Specific safety data sheets (SDS) and material safety data sheets (MSDS) must be prepared and distributed to ensure safe handling and use.

Are there alternatives to Osteogenic Growth Peptide (CAS: 132996-61-3) in synthesis?

In the synthesis of Osteogenic Growth Peptide (OGP), there are several alternatives such as using analogs like Bone Morphogenetic Proteins (BMPs) or other growth factors. Isomers and common alternative reagents like recombinant proteins can also be considered as substitutes to achieve similar biological effects.

What is the market or research trend for Osteogenic Growth Peptide (CAS: 132996-61-3)?

The market for Osteogenic Growth Peptide (OGP) is growing due to increasing demand in bone regenerative medicine and orthopedic applications. Research trends are focusing on optimizing delivery methods and exploring its potential in other therapeutic areas like dental and spinal treatments. Price trends indicate a steady market value, reflecting growing interest from both academic and industrial sectors.

How should waste containing Osteogenic Growth Peptide (CAS: 132996-61-3) be handled?

Waste containing Osteogenic Growth Peptide (OGP) should be collected in appropriate containers and disposed of through professional waste disposal services. Environmental precautions include ensuring no contamination of soil or water. Incineration is a common method for disposal, but it must be done in compliance with local regulations to prevent air pollution. Chemical neutralization or biological treatment can also be used based on local regulations and environmental impact assessments.